Diagnósticos da América S.A (DASA3) - Total Assets
Based on the latest financial reports, Diagnósticos da América S.A (DASA3) holds total assets worth R$21.10 Billion BRL (≈ $4.14 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Diagnósticos da América S.A for net asset value and shareholders' equity analysis.
Diagnósticos da América S.A - Total Assets Trend (2000–2024)
This chart illustrates how Diagnósticos da América S.A's total assets have evolved over time, based on quarterly financial data.
Diagnósticos da América S.A - Asset Composition Analysis
Current Asset Composition (December 2024)
Diagnósticos da América S.A's total assets of R$21.10 Billion consist of 31.0% current assets and 69.0% non-current assets.
| Asset Category | Amount (BRL) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$1.58 Billion | 6.6% |
| Accounts Receivable | R$4.95 Billion | 18.7% |
| Inventory | R$465.54 Million | 1.8% |
| Property, Plant & Equipment | R$6.19 Billion | 23.4% |
| Intangible Assets | R$1.53 Billion | 5.8% |
| Goodwill | R$8.56 Billion | 32.4% |
Asset Composition Trend (2000–2024)
This chart illustrates how Diagnósticos da América S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Diagnósticos da América S.A worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Diagnósticos da América S.A's current assets represent 31.0% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 6.6% of total assets in 2024, up from 1.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 32.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 32.4% of total assets.
Diagnósticos da América S.A Competitors by Total Assets
Key competitors of Diagnósticos da América S.A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$54.63 Million |
|
Leveljump Healthcare Corp
V:JUMP
|
Canada | CA$21.84 Million |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Diagnósticos da América S.A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 1.65 | 1.40 |
| Quick Ratio | 1.19 | 1.57 | 1.28 |
| Cash Ratio | 0.41 | 0.34 | 0.00 |
| Working Capital | R$1.22 Billion | R$3.78 Billion | R$1.20 Billion |
Diagnósticos da América S.A - Advanced Valuation Insights
This section examines the relationship between Diagnósticos da América S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.67 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | R$26.46 Billion |
| Market Capitalization | $828.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values Diagnósticos da América S.A's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Diagnósticos da América S.A's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Diagnósticos da América S.A (2000–2024)
The table below shows the annual total assets of Diagnósticos da América S.A from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | R$26.46 Billion ≈ $5.19 Billion |
+0.94% |
| 2023-12-31 | R$26.21 Billion ≈ $5.14 Billion |
-2.35% |
| 2022-12-31 | R$26.84 Billion ≈ $5.27 Billion |
+15.46% |
| 2021-12-31 | R$23.25 Billion ≈ $4.56 Billion |
+74.24% |
| 2020-12-31 | R$13.34 Billion ≈ $2.62 Billion |
+50.96% |
| 2019-12-31 | R$8.84 Billion ≈ $1.73 Billion |
+22.37% |
| 2018-12-31 | R$7.22 Billion ≈ $1.42 Billion |
+15.64% |
| 2017-12-31 | R$6.25 Billion ≈ $1.23 Billion |
+20.96% |
| 2016-12-31 | R$5.16 Billion ≈ $1.01 Billion |
+10.30% |
| 2015-12-31 | R$4.68 Billion ≈ $918.65 Million |
+1.57% |
| 2014-12-31 | R$4.61 Billion ≈ $904.47 Million |
-1.75% |
| 2013-12-31 | R$4.69 Billion ≈ $920.62 Million |
+9.82% |
| 2012-12-31 | R$4.27 Billion ≈ $838.28 Million |
-0.25% |
| 2011-12-31 | R$4.28 Billion ≈ $840.36 Million |
+120.20% |
| 2010-12-31 | R$1.94 Billion ≈ $381.63 Million |
+17.39% |
| 2009-12-31 | R$1.66 Billion ≈ $325.11 Million |
-10.43% |
| 2008-12-31 | R$1.85 Billion ≈ $362.95 Million |
+51.81% |
| 2007-12-31 | R$1.22 Billion ≈ $239.08 Million |
+19.61% |
| 2006-12-31 | R$1.02 Billion ≈ $199.88 Million |
+74.09% |
| 2005-12-31 | R$585.13 Million ≈ $114.81 Million |
+10.07% |
| 2004-12-31 | R$531.60 Million ≈ $104.31 Million |
+49.87% |
| 2003-12-31 | R$354.72 Million ≈ $69.60 Million |
+7.87% |
| 2002-12-31 | R$328.84 Million ≈ $64.52 Million |
+24.83% |
| 2001-12-31 | R$263.43 Million ≈ $51.69 Million |
+66.68% |
| 2000-12-31 | R$158.04 Million ≈ $31.01 Million |
-- |
About Diagnósticos da América S.A
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care c… Read more